Targeting cancer antigens using the adoptive transfer of genetically engineered lymphocytes

被引：0
|
作者：
Rosenberg, S. [1 ]
机构：
[1] NCI, NIH, Bethesda, MD 20892 USA
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [21] Genetically engineered T-cells for adoptive immunotherapy
    Pule, M
    Bollard, CM
    Heslop, HE
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2002, 4 (05) : 467 - 475
  • [22] Cancer immunotherapy by genetically engineered effector lymphocytes redirected by chimeric receptors
    Eshhar, Z
    Pinthus, JH
    Waks, T
    Bendavid, A
    Schindler, DG
    FASEB JOURNAL, 2001, 15 (05): : A1200 - A1200
  • [23] Adoptive cell therapy with genetically engineered t-cells for epithelial ovarian cancer
    Maffia, Maria Chiara
    Ruggiero, Eliana
    Tassi, Elena
    Magnani, Zulma
    Bergamini, Alice
    Mangili, Giorgia
    Candotti, Giorgio
    Bocciolone, Luca
    Pavone, Giacomo
    Rabaiotti, Emanuela
    Sabini, Carlotta
    Cioffi, Raffaella
    Parretta, Mariangela
    Candiani, Massimo
    Sant'angelo, Miriam
    Doglioni, Claudio
    Schultes, Birgit
    Prodeus, Aaron
    Bonini, Chiara
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A511 - A511
  • [24] T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy
    Yamamoto, Tori N.
    Lee, Ping-Hsien
    Vodnala, Suman K.
    Gurusamy, Devikala
    Kishton, Rigel J.
    Yu, Zhiya
    Eidizadeh, Arash
    Eil, Robert
    Fioravanti, Jessica
    Gattinoni, Luca
    Kochenderfer, James N.
    Fry, Terry J.
    Aksoy, Bulent Arman
    Hammerbacher, Jeffrey E.
    Cruz, Anthony C.
    Siegel, Richard M.
    Restifo, Nicholas P.
    Klebanoff, Christopher A.
    JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (04): : 1551 - 1565
  • [25] Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptor
    Joseph, Jocelyn
    Nathenson, Michael J.
    Van Anh Trinh
    Malik, Karan
    Nowell, Erica
    Carter, Kristen
    Weathers, Shiao-Pei
    Demetri, George D.
    Araujo, Dejka
    Conley, Anthony P.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [26] Targeting Autophagy Enhances the Adoptive Immunotherapy of Glioblastoma with Multi-Functional Genetically-Engineered NK Cells
    Wang, Jiao
    Matosevic, Sandro
    MOLECULAR THERAPY, 2019, 27 (04) : 457 - 458
  • [27] Cancer immunotherapy with lymphocytes genetically engineered with T cell receptors for solid cancers
    Chen, Lei
    Qiao, Dongjuan
    Wang, Juntao
    Tian, Geng
    Wang, Mingjun
    IMMUNOLOGY LETTERS, 2019, 216 : 51 - 62
  • [28] Redirecting genetically engineered effector lymphocytes to cancer using the T-body approach: Toward clinical trials
    Eshhar, Z
    Pinthus, YH
    Bendavid, A
    Waks, T
    Daniel, G
    CANCER GENE THERAPY, 2001, 8 (09) : 684 - 684
  • [29] Genetically Redirected T Lymphocytes for Adoptive Immunotherapy of Solid Tumors
    Leuci, Valeria
    Mesiano, Giulia
    Gammaitoni, Loretta
    Aglietta, Massimo
    Sangiolo, Dario
    CURRENT GENE THERAPY, 2014, 14 (01) : 52 - 62
  • [30] Development of NT3 Genetically Engineered cells using human Lymphocytes
    MA Xiao-feng1
    Journal of Otology, 2010, 5 (01) : 40 - 45
12345